Ignite Creation Date:
2026-03-26 @ 3:18 PM
Ignite Modification Date:
2026-03-31 @ 1:54 AM
Study NCT ID:
NCT07363967
Status:
RECRUITING
Last Update Posted:
2026-01-23
First Post:
2026-01-15
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Phase I First-in-Human Open-Label Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Anti-Tumor Activity of SWA1211 Tablets in Subjects With Advanced Solid Tumors
Sponsor:
Beijing StoneWise Technology Co., Ltd
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2025-06-13
Start Date Type:
ACTUAL
Primary Completion Date:
2027-09-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2028-02-01
Completion Date Type:
ESTIMATED
First Submit Date:
2026-01-15
First Submit QC Date:
None
Study First Post Date:
2026-01-23
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2026-01-15
Last Update Post Date:
2026-01-23
Last Update Post Date Type:
ACTUAL